Takalsitoli
Takalsitoli (kwa Kiingereza: Tacalcitol), inayouzwa kwa majina ya chapa Curatoderm na mengine, ni dawa inayotumika kutibu makovu makavu yanayowasha (psoriasis), haswa kovu la tauni.[1][2] Dawa hii inatumika juu ya ngozi mara moja hadi mbili kwa siku.[1][3]
Madhara yake yanaweza kujumuisha upele wa ngozi na kalsiamu nyingi.[1] Ni analogi ya vitamini <sub id="mwHw">D3</sub> inayotengenezwa.[3]
Takalsitoli iliidhinishwa kwa ajili ya matumizi ya kimatibabu nchini Japani mwaka wa 1993.[4] Iko kwenye Orodha ya Shirika la Afya Ulimwenguni ya Dawa Muhimu kama njia mbadala ya kalsipotriolo (calcipotriol).[5] Nchini Uingereza, gramu 30 hugharimu Huduma ya kitaifa ya Afya (NHS) takriban £13 kufikia mwaka wa 2023.[6]
Marejeo
- ↑ 1.0 1.1 1.2 "Tacalcitol". NICE. Ilihifadhiwa kwenye nyaraka kutoka chanzo mnamo 10 Septemba 2023. Iliwekwa mnamo 9 Septemba 2023.
{cite web}: CS1 maint: date auto-translated (link) - ↑ "eEML - Electronic Essential Medicines List". list.essentialmeds.org. Ilihifadhiwa kwenye nyaraka kutoka chanzo mnamo 10 Juni 2023. Iliwekwa mnamo 9 Septemba 2023.
{cite web}: CS1 maint: date auto-translated (link) - ↑ 3.0 3.1 Peters DC, Balfour JA (Agosti 1997). "Tacalcitol". Drugs. 54 (2): 265–71, discussion 272. doi:10.2165/00003495-199754020-00005. PMID 9257082.
{cite journal}: CS1 maint: date auto-translated (link) - ↑ Tarutani, M (Oktoba 2004). "[Vitamin D3 for external application--history of development and clinical application]". Clinical calcium. 14 (10): 124–8. PMID 15577144.
{cite journal}: CS1 maint: date auto-translated (link) - ↑ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
- ↑ "Tacalcitol Medicinal forms". NICE. Ilihifadhiwa kwenye nyaraka kutoka chanzo mnamo 10 Septemba 2023. Iliwekwa mnamo 9 Septemba 2023.
{cite web}: CS1 maint: date auto-translated (link)